HBM Healthcare Investments AG For Profit
As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures' portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
Invests into
.jpg)
Funding Status:
Active
Industry:
Biotechnology, Finance, Financial Services, Medical, Venture Capital
Estimated Revenue:
$500M to $1B
Acquisitions Number:
Made Acquisitions
Number Of Exists:
68
Headquarters:
Zug, Zug, Switzerland
Investor Type:
Venture Capital
Employee Number:
1001-5000
Investors Number:
238
Investment Stage:
Late Stage Venture, Private Equity
Founded Date:
2001-07-12